Humacyte (HUMA) Debt to Equity (2020 - 2025)

Humacyte (HUMA) reported Debt to Equity of -$4.37 for Q3 2025, down 347.94% year-over-year from $1.76 in Q3 2024, and down 125.81% quarter-over-quarter from $16.92 in Q2 2025.

Humacyte (HUMA) Debt to Equity (2020 - 2025) Analysis & Trends

Humacyte (HUMA) has 6 years of Debt to Equity data on file, last reported at -$4.37 in Q3 2025.

  • Debt to Equity for Q3 2025 came in at -$4.37, down 347.94% year-over-year; the trailing twelve-month figure through Sep 2025 was -$4.37 (down 347.94% YoY), and the FY2024 annual result was -$1.24, down 143.37% from the prior year.
  • Debt to Equity declined to -$4.37 in Q3 2025 per HUMA's latest filing, from $16.92 in the prior quarter.
  • Over five years, Debt to Equity peaked at $16.92 in Q2 2025 and troughed at -$4.37 in Q3 2025.
  • A 5-year average of $1.02 and a median of $0.24 in 2021 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2021 and 2024: Debt to Equity jumped 1828881.89% in 2021, then sank 458.1% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.22 in 2021, then slumped by 67.27% to $0.07 in 2022, then soared by 3787.44% to $2.85 in 2023, then tumbled by 143.37% to -$1.24 in 2024, then plunged by 253.36% to -$4.37 in 2025.
  • Business Quant data shows HUMA's Debt to Equity at -$4.37 in Q3 2025, $16.92 in Q2 2025, and $1.84 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Humacyte 267.09 Mn 218.55 Mn -1.54 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -4.37
Jun 30, 2025 16.92
Mar 31, 2025 1.84
Dec 31, 2024 -1.24
Sep 30, 2024 -0.97
Jun 30, 2024 -2.12
Mar 31, 2024 2.22
Dec 31, 2023 2.85
Jun 30, 2023 0.59
Mar 31, 2023 0.36
Dec 31, 2022 0.07
Sep 30, 2022 0.24
Jun 30, 2022 0.20
Mar 31, 2022 0.27
Dec 31, 2021 0.22
Sep 30, 2021 0.24
Mar 31, 2021 0.00
Dec 31, 2020 -0.01
Sep 30, 2020 0.00